Philip Parkinson
Nessuna posizione attualmente
Profilo
Philip Parkinson served as Chairman & CEO of Nautilus Biotech SA, Finance Director at Pfizer, Inc., and CFO at Novagali Pharma SA from 2009 to 2011.
He received an undergraduate degree from Université Libre de Bruxelles.
Precedenti posizioni note di Philip Parkinson
| Società | Posizione | Fine |
|---|---|---|
| Pfizer, Inc. /Angers & Val-de-Reuil Pharmaceutical Operations | Direttore Finanziario/CFO | - |
Nautilus Biotech SA
 Nautilus Biotech SA Pharmaceuticals: MajorHealth Technology Nautilus Biotech SA develops and markets innovative biotechnology products. The company focuses on improving and developing protein pharmaceuticals. The firm was founded in 1999 and is headquartered in Evry, France. | Presidente | - |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Direttore Finanziario/CFO | - |
Formazione di Philip Parkinson
| Université Libre de Bruxelles | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Nautilus Biotech SA
Nautilus Biotech SA Pharmaceuticals: MajorHealth Technology Nautilus Biotech SA develops and markets innovative biotechnology products. The company focuses on improving and developing protein pharmaceuticals. The firm was founded in 1999 and is headquartered in Evry, France. | Health Technology |
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Health Technology |
| Pfizer, Inc. /Angers & Val-de-Reuil Pharmaceutical Operations | Health Technology |
- Borsa valori
- Insiders
- Philip Parkinson
